Title | The carboxy-terminus of the human ARPKD protein fibrocystin can control STAT3 signalling by regulating SRC-activation. |
Publication Type | Journal Article |
Year of Publication | 2020 |
Authors | Dafinger, C, Mandel, AM, Braun, A, Göbel, H, Burgmaier, K, Massella, L, Mastrangelo, A, Dötsch, J, Benzing, T, Weimbs, T, Schermer, B, Liebau, MC |
Journal | J Cell Mol Med |
Volume | 24 |
Pagination | 14633–14638 |
Date Published | 2020 Oct 28 |
ISSN | 1582-4934 |
Abstract | Autosomal recessive polycystic kidney disease (ARPKD) is mainly caused by variants in the PKHD1 gene, encoding fibrocystin (FC), a large transmembrane protein of incompletely understood cellular function. Here, we show that a C-terminal fragment of human FC can suppress a signalling module of the kinase SRC and signal transducer and activator of transcription 3 (STAT3). Consistently, we identified truncating genetic variants specifically affecting the cytoplasmic tail in ARPKD patients, found SRC and the cytoplasmic tail of fibrocystin in a joint dynamic protein complex and observed increased activation of both SRC and STAT3 in cyst-lining renal epithelial cells of ARPKD patients. |
DOI | 10.1111/jcmm.16014 |
Alternate Journal | J Cell Mol Med |
PubMed ID | 33112055 |
Grant List | DK109563 / NH / NIH HHS / United States DK62338 / NH / NIH HHS / United States LI 2397 5/1 / / Deutsche Forschungsgemeinschaft / SCHE 1562/6 / / Deutsche Forschungsgemeinschaft / / / Marga und Walter Boll-Stiftung / Medical Faculty: Koeln Fortune Program / / Universität zu Köln / 01GM1515E / / Bundesministerium für Bildung und Forschung / 01GM1903B / / Bundesministerium für Bildung und Forschung / |